作者
Victor F Tapson, Hervé Decousus, Mario Pini, Beng H Chong, James B Froehlich, Manuel Monreal, Alex C Spyropoulos, Geno J Merli, Rainer B Zotz, Jean-François Bergmann, Ricardo Pavanello, Alexander GG Turpie, Mashio Nakamura, Franco Piovella, Ajay K Kakkar, Frederick A Spencer, Gordon FitzGerald, Frederick A Anderson Jr, Improve Investigators
发表日期
2007/9/1
期刊
Chest
卷号
132
期号
3
页码范围
936-945
出版商
Elsevier
简介
Background
Evidence-based guidelines recommend that acutely ill hospitalized medical patients who are at risk of venous thromboembolism (VTE) should receive prophylaxis. Our aim was to characterize the clinical practices for VTE prophylaxis in acutely ill hospitalized medical patients enrolled in the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE).
Methods
IMPROVE is an ongoing, multinational, observational study. Participating hospitals enroll the first 10 consecutive eligible acutely ill medical patients each month. Patient management is determined by the treating physicians. An analysis of data on VTE prophylaxis practices is presented.
Results
From July 2002 to September 30, 2006, 15,156 patients were enrolled from 52 hospitals in 12 countries, of whom 50% received in-hospital pharmacologic and/or mechanical VTE prophylaxis. In the United States and other …
引用总数
学术搜索中的文章
VF Tapson, H Decousus, M Pini, BH Chong… - Chest, 2007